CareRx Corporation
CRRX.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -2.58% | -3.07% | -4.04% | -4.81% | -6.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.58% | -3.07% | -4.04% | -4.81% | -6.40% |
| Cost of Revenue | -4.24% | -4.48% | -5.62% | -5.15% | -5.63% |
| Gross Profit | 1.64% | 0.56% | 0.05% | -3.93% | -8.30% |
| SG&A Expenses | 1.87% | -2.56% | -2.78% | -5.46% | -8.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.60% | -3.96% | -4.86% | -5.24% | -6.29% |
| Operating Income | -1.56% | 59.74% | 56.75% | 20.91% | -12.09% |
| Income Before Tax | 54.40% | 38.78% | 33.76% | 78.37% | 74.57% |
| Income Tax Expenses | 100.73% | 95.19% | 95.78% | -170.63% | -154.90% |
| Earnings from Continuing Operations | 18.11% | 7.08% | -3.60% | 89.37% | 85.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.11% | 7.08% | -3.60% | 89.37% | 85.08% |
| EBIT | -1.56% | 59.74% | 56.75% | 20.91% | -12.09% |
| EBITDA | -4.71% | 4.18% | -5.02% | -5.14% | -11.17% |
| EPS Basic | 22.33% | 20.34% | 14.45% | 91.37% | 87.69% |
| Normalized Basic EPS | 63.88% | 80.36% | 58.21% | -17.26% | -180.12% |
| EPS Diluted | 24.51% | 22.02% | 16.08% | 91.00% | 87.35% |
| Normalized Diluted EPS | 63.03% | 80.03% | 57.50% | -13.68% | -173.68% |
| Average Basic Shares Outstanding | 5.08% | 8.49% | 12.68% | 17.42% | 20.49% |
| Average Diluted Shares Outstanding | 2.61% | 5.84% | 9.79% | 20.19% | 23.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |